We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-2.92%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$1.93B
AUM Growth
-$130M
Cap. Flow
-$54.2M
Cap. Flow %
-2.81%
Top 10 Hldgs %
30.03%
Holding
2,489
New
31
Increased
1,105
Reduced
525
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Healthcare 11.48%
3 Financials 10.72%
4 Consumer Discretionary 9.28%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKHS icon
2451
Workhorse Group
WKHS
$33.7M
-3
Closed -$7.18K
XAIR icon
2452
Beyond Air
XAIR
$5.23M
-4
Closed -$6.04K
ZGN icon
2453
Zegna
ZGN
$3.76B
-1
Closed -$13
MAGN
2454
Magnera Corp
MAGN
$441M
-186
Closed -$7.32K
WHWK
2455
Whitehawk Therapeutics
WHWK
$268M
-812
Closed -$5.55K
TVRD
2456
Tvardi Therapeutics
TVRD
$22.4M
-69
Closed -$7.05K
VOXX
2457
DELISTED
VOXX International Corporation Class A
VOXX
-771
Closed -$9.62K
OMGA
2458
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-1,423
Closed -$7.97K
AKTS
2459
DELISTED
Akoustis Technologies Inc
AKTS
-3,629
Closed -$11.5K
BHIL
2460
DELISTED
Benson Hill, Inc.
BHIL
-285
Closed -$13K
NGM
2461
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-2,246
Closed -$5.82K
CRGE
2462
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
-8,134
Closed -$7.97K
THRX
2463
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-1,126
Closed -$10.5K
NSTG
2464
DELISTED
NanoString Technologies, Inc.
NSTG
-2,560
Closed -$10.4K
CANO
2465
DELISTED
Cano Health, Inc.
CANO
-135
Closed -$18.8K
TRTN
2466
DELISTED
Triton International Limited
TRTN
-2,983
Closed -$248K
RETA
2467
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-1,561
Closed -$159K
RADI
2468
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
-4,680
Closed -$69.7K
RTL
2469
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-11,339
Closed -$76.7K
QUOT
2470
DELISTED
Quotient Technology Inc
QUOT
-5,001
Closed -$19.2K
NEX
2471
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-10,638
Closed -$95.1K
NUVA
2472
DELISTED
NuVasive, Inc.
NUVA
-2,906
Closed -$121K
FOCS
2473
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-3,182
Closed -$167K
FORG
2474
DELISTED
ForgeRock, Inc.
FORG
-2,614
Closed -$53.7K
FRG
2475
DELISTED
Franchise Group, Inc.
FRG
-1,246
Closed -$35.7K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2023 Portfolio in Review

As of Q3 2023, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $1.93B, down 6.3% from $2.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.9%. Metropolitan Life Insurance Company (MetLife) opened 31 new positions and exited 91, leaving the 2,489-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2023 buy was Vanguard Long-Term Corporate Bond ETF: 296,480 shares worth $21.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q3 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $10.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited State Street SPDR Portfolio Long Term Corporate Bond ETF in Q3 2023, selling an estimated $23.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $1.93B portfolio in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 31 new positions and closed 91 in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 6.3% quarter-over-quarter to $1.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.